Shows
In the Money with Amber KanwarIs Passive Investing Quietly Breaking the Market?What if the biggest risk to the S&P 500 isn’t a recession, rates, or geopolitics — but the way we invest?Amber Kanwar sits down with Michael Green, Portfolio Manager & Chief Strategist, Simplify Asset Management , to unpack a provocative — and deeply unsettling — idea: under certain conditions, the S&P 500 could theoretically go to zero. Not because every company fails, but because market structure breaks.Green explains how the explosive growth of passive investing has quietly changed how markets behave, why flows now matter more than fundamentals, and how index-driven buying can amplify momentum on the way up —...
2026-01-291h 03
Globaler Marktzugang für MedizinprodukteCompanion Diagnostics (CDx) und die EU-IVDR: Regulatorische Hürden meisternIn dieser Folge befassen wir uns mit den erheblichen Herausforderungen, die die europäische In-vitro-Diagnostika-Verordnung (IVDR) für Hersteller von Companion Diagnostics (CDx) mit sich bringt. Wir erörtern die höheren Risikoklassen, die komplexen Konsultationsverfahren mit Arzneimittelbehörden wie der EMA und die gestiegenen Anforderungen an klinische Nachweise. Die Episode beleuchtet, warum die strategische Abstimmung zwischen Diagnostika- und Pharma-Partnern entscheidend für einen erfolgreichen Markteintritt ist.
- Was ändert die IVDR konkret für Companion Diagnostics?
- Warum werden CDx jetzt in höhere Risikoklassen eingestuft?
- Wie funktioniert der Konsultationsprozess mit den Arzneimittelbehörden?
- Welche neuen Anforderungen an klinisc...
2026-01-2803 min
의료기기 글로벌 시장 진입유럽 IVDR 동반진단(CDx) 규제: EMA 상담 및 의약품 연계 전략이번 에피소드에서는 유럽의 체외진단 의료기기 규정(IVDR)이 동반진단(CDx) 기기에 부과하는 복잡한 규제 요건에 대해 자세히 알아봅니다. C 또는 D 등급으로 상향된 위험 분류, 유럽의약품청(EMA)과 같은 의약품 규제 당국과의 의무적인 상담 절차, 그리고 제약 파트너와의 필수적인 협력 관계가 시장 출시 타임라인에 미치는 영향을 심도 있게 분석합니다.
- IVDR은 동반진단(CDx)의 위험 등급을 어떻게 변경했으며, 이것이 제조업체에 의미하는 바는 무엇인가요?
- 동반진단 기기 인증 시 인증기관(Notified Body)이 유럽의약품청(EMA)과 반드시 상담해야 하는 경우는 언제인가요?
- 의약품-진단기기 연계(drug-device linkage)란 무엇이며, IVDR 하에서 왜 중요한가요?
- 새로운 규정 하에서 요구되는 임상적 증거의 수준은 이전과 어떻게 다른가요?
- 제약 파트너와의 협력이 동반진단 기기의 성공적인 시장 출시에 왜 필수적인가요?
- IVDR 규제 타임라인을 관리하기 위해 기업이 취해야 할 핵심 전략은 무엇인가요?
- 동반진단 기기의 적합성 평가에서 가장 시간이 많이 소요되는 단계는 무엇인가요?
Pure Global은 의료 기술(MedTech) 및 체외진단(IVD) 기업을 위한 종합적인 규제 컨설팅 솔루션을 제공하며, 현지 전문성과 고급 AI 및 데이터 도구를 결합하여 글로벌 시장 접근을 효율화합니다. 저희는 30개 이상의 시장에서 현지 대리인 역할을 수행하며, 규제 전략 수립부터 기술 문서 제출까지 지원합니다. AI 기술을 활용하여 기술 문서를 효율적으로 취합하고 제출하며, 규제 변경 사항을 지속적으로 모니터링하여 시장 지위를 유지할 수 있도록 돕습니다. 귀사의 혁신 기술을 더 빠르고 안전하게 글로벌 시장에 출시할 수 있도록 Pure Global이 함께 하겠습니다. 자세한 내용은 웹사이트 https://pureglobal.com/를 방문하시거나 info@pureglobal.com으로 문의해 주십시오. 무료 AI 규제 데이터베이스는 https://pureglobal.ai/에서 확인하실 수 있습니다.
2026-01-2803 min
医療機器グローバル市場アクセスEU IVDR下のコンパニオン診断薬（CDx）：薬事承認における規制上の課題と戦略本エピソードでは、2022年5月26日に完全適用された欧州の体外診断用医療機器規則（IVDR）が、コンパニオン診断薬（CDx）の市場投入に与える影響を解説します。特に、医薬品との連携、ノーティファイドボディと医薬品規制当局（EMA等）との協議プロセス、そして臨床的エビデンス要件の厳格化という、企業が直面する主要な課題に焦点を当てます。
- IVDR下でコンパニオン診断薬（CDx）はどのようにクラス分類されますか？
- なぜノーティファイドボディは医薬品規制当局との協議が必須なのですか？
- CDxに求められる「臨床的有用性」のエビデンスとは具体的に何ですか？
- 製薬企業パートナーとの連携は、なぜこれまで以上に重要になったのですか？
- 薬事承認のタイムラインが遅延する最大のリスクは何ですか？
- 薬とデバイスの承認プロセスを同期させるための戦略とは？
- IVDRへの移行で、既存の診断薬にはどのような影響がありますか？
Pure Globalは、MedTechおよびIVD企業向けに、エンドツーエンドの薬事コンサルティングソリューションを提供します。各国現地法人による専門知識と高度なAI・データツールを組み合わせ、グローバル市場へのアクセスを合理化します。欧州IVDRのような複雑な規制環境下でのコンパニオン診断薬の承認戦略、ノーティファイドボディとの折衝、技術文書の作成など、製品ライフサイクル全体をサポートします。貴社の迅速な市場参入を支援する方法については、ウェブサイト https://pureglobal.com/ をご覧いただくか、info@pureglobal.com までお問い合わせください。また、https://pureglobal.ai で無料のAIツールやデータベースもご利用いただけます。
2026-01-2803 min
Akses Pasar Global Alat KesehatanStrategi IVDR Eropa: Menavigasi Kompleksitas Companion Diagnostics (CDx) dan Kemitraan Obat-Alat KesehatanEpisode ini membahas kompleksitas yang dihadapi oleh produsen diagnostik pendamping (Companion Diagnostics - CDx) di bawah Peraturan Diagnostik In Vitro (IVDR) Uni Eropa yang baru. Kami menguraikan bagaimana klasifikasi risiko yang lebih tinggi, keterlibatan wajib Notified Body, dan proses konsultasi yang rumit dengan otoritas obat telah mengubah lanskap regulasi. Kami juga menyoroti peningkatan tuntutan untuk bukti klinis dan pentingnya kemitraan strategis antara perusahaan diagnostik dan farmasi untuk memastikan keberhasilan akses pasar.
- Apa itu Companion Diagnostics (CDx) dan mengapa mereka penting dalam pengobatan presisi?
- Bagaimana Peraturan IVDR Uni Eropa mengubah klasifikasi risiko untuk CDx sejak 26 Mei 2022?
- Mengapa keterlibatan...
2026-01-2803 min
Akses Pasaran Global Peranti PerubatanMenavigasi Kerumitan IVDR untuk Diagnostik Dampingan (CDx) di EropahEpisod ini membincangkan cabaran kompleks yang dihadapi oleh pengeluar peranti perubatan dalam mendapatkan kelulusan untuk Diagnostik Dampingan (Companion Diagnostics atau CDx) di bawah Peraturan Diagnostik In-Vitro (IVDR) Eropah yang ketat. Kami meneroka bagaimana IVDR, yang berkuat kuasa sepenuhnya pada 26 Mei 2022, meningkatkan keperluan untuk penyelarasan antara rakan kongsi farmaseutikal, bukti klinikal yang kukuh, dan laluan perundingan mandatori, yang sering meletakkan CDx dalam kelas risiko yang lebih tinggi dan di bawah pengawasan yang lebih ketat.
Soalan-soalan Utama:
- Apakah itu Diagnostik Dampingan (CDx) dan mengapa ia penting dalam perubatan moden?
- Bagaimanakah Peraturan IVDR Eropah (EU 2017/746) mengubah landskap pengawalseliaan untuk CDx?
...
2026-01-2803 min
การเข้าถึงตลาดเครื่องมือแพทย์ระดับโลกIVDR และ Companion Diagnostics: สิ่งที่ผู้ผลิตต้องรู้เพื่อเข้าสู่ตลาดยุโรปในตอนนี้ เราจะเจาะลึกถึงความท้าทายที่สำคัญสำหรับผู้ผลิต Companion Diagnostics (CDx) ในการเข้าสู่ตลาดยุโรปภายใต้กฎระเบียบ IVDR ฉบับใหม่ เราจะสำรวจว่าเหตุใด CDx จึงถูกจัดอยู่ในกลุ่มความเสี่ยงที่สูงขึ้น กระบวนการปรึกษาหารือกับหน่วยงานด้านยาที่จำเป็น และข้อกำหนดด้านหลักฐานทางคลินิกที่เข้มงวดขึ้น ซึ่งทั้งหมดนี้ส่งผลกระทบโดยตรงต่อระยะเวลาและกลยุทธ์การเข้าสู่ตลาด
- กฎระเบียบ IVDR ของสหภาพยุโรปเปลี่ยนแปลงภูมิทัศน์สำหรับ Companion Diagnostics (CDx) อย่างไร?
- เหตุใด CDx ส่วนใหญ่จึงถูกจัดอยู่ในกลุ่มความเสี่ยงสูง Class C ภายใต้ IVDR และมีความหมายอย่างไร?
- กระบวนการปรึกษาหารือภาคบังคับระหว่าง Notified Body และหน่วยงานด้านยาคืออะไร และส่งผลต่อระยะเวลาอย่างไร?
- ข้อกำหนดด้านหลักฐานทางคลินิก (clinical evidence) สำหรับ CDx ภายใต้ IVDR มีความเข้มงวดมากขึ้นในด้านใดบ้าง?
- การวางแผนร่วมกันระหว่างบริษัทผู้ผลิตยาและผู้ผลิตเครื่องมือแพทย์มีความสำคัญต่อความสำเร็จของ CDx มากน้อยเพียงใด?
- อะไรคือความเสี่ยงที่ใหญ่ที่สุดหากกลยุทธ์ด้านกฎระเบียบของยาและเครื่องมือแพทย์ไม่สอดคล้องกัน?
Pure Global นำเสนอโซลูชันที่ปรึกษาด้านกฎระเบียบแบบครบวงจรสำหรับบริษัทเทคโนโลยีการแพทย์ (MedTech) และเครื่องมือวินิจฉัยภายนอกร่างกาย (IVD) เราผสมผสานความเชี่ยวชาญในแต่ละประเทศเข้ากับเครื่องมือ AI และข้อมูลที่ทันสมัย เพื่อปรับปรุงกระบวนการเข้าสู่ตลาดโลกให้มีประสิทธิภาพและรวดเร็วยิ่งขึ้น บริการของเราครอบคลุมตั้งแต่การพัฒนากลยุทธ์ด้านกฎระเบียบ การจัดทำเอกสารทางเทคนิค ไปจนถึงการเป็นตัวแทนในกว่า 30 ประเทศทั่วโลก ช่วยให้คุณสามารถขยายตลาดได้อย่างมั่นใจ ติดต่อเราได้ที่ info@pureglobal.com หรือเยี่ยมชมเว็บไซต์ https://pureglobal.com เพื่อดูข้อมูลเพิ่มเติม และสำรวจเครื่องมือ AI กับฐานข้อมูลฟรีได้ที่ https://pureglobal.ai
2026-01-2802 min
Tiếp cận Thị trường Toàn cầu cho Thiết bị Y tếĐiều Hướng CDx theo IVDR của EU: Thách Thức về Phối Hợp và Bằng Chứng Lâm SàngTập này đi sâu vào những thách thức phức tạp trong việc đưa Chẩn đoán Đồng hành (Companion Diagnostics - CDx) ra thị trường Liên minh Châu Âu theo Quy định về Trang thiết bị Y tế Chẩn đoán In Vitro (IVDR). Chúng tôi thảo luận về các yêu cầu khắt khe liên quan đến mối liên kết giữa thuốc và thiết bị, các lộ trình đánh giá sự phù hợp phức tạp cho các thiết bị rủi ro cao, và tầm quan trọng của...
2026-01-2803 min
Tıbbi Cihazlar Küresel Pazar ErişimiAvrupa IVDR Kapsamında Refakatçi Tanı (CDx) Onayı: İlaç-Cihaz Koordinasyon ZorluklarıBu bölümde, Avrupa Birliği'nin In Vitro Diagnostik Tıbbi Cihaz Tüzüğü (IVDR) kapsamında Refakatçi Tanı Kitlerinin (Companion Diagnostics - CDx) karşılaştığı yeni düzenleyici zorlukları ele alıyoruz. Artan risk sınıflandırmaları, Onaylanmış Kuruluş ve Avrupa İlaç Ajansı (EMA) ile zorunlu danışma süreçleri ve ilaç-cihaz geliştirme takvimlerini senkronize etme ihtiyacı gibi kritik konuları inceliyoruz.
- Refakatçi Tanı (CDx) nedir ve IVDR kapsamında neden özel bir yere sahiptir?
- IVDR, CDx'in risk sınıflandırmasını nasıl değiştirdi ve bu üreticiler için ne anlama geliyor?
- Bir CDx'in CE i...
2026-01-2803 min
Globalny Dostęp do Rynku Wyrobów MedycznychIVDR a Diagnostyka Towarzysząca (CDx): Wyzwania i Strategie dla Rynku UEW tym odcinku omawiamy nowe wyzwania regulacyjne dla diagnostyki towarzyszącej (CDx) w Unii Europejskiej, wprowadzone przez rozporządzenie IVDR. Wyjaśniamy, dlaczego testy CDx są teraz klasyfikowane jako wyroby wysokiego ryzyka (klasa C), jakie są implikacje obowiązkowych konsultacji z agencjami lekowymi, takimi jak EMA, oraz jakie nowe, rygorystyczne wymagania dotyczące dowodów klinicznych muszą spełnić producenci, aby uzyskać certyfikat CE i z sukcesem wprowadzić swój produkt na rynek.
- Jakie są kluczowe różnice dla CDx między dyrektywą IVDD a rozporządzeniem IVDR?
- Dlaczego większość testów CDx jest teraz klasyfikowana jako klasa C?
- Na czym poleg...
2026-01-2804 min
Globalt Marknadstillträde för Medicintekniska ProdukterIVDR & Companion Diagnostics (CDx): Krav, Klassificering och Samordning i EUDetta avsnitt utforskar de avsevärda utmaningarna med att få ut Companion Diagnostics (CDx) på den europeiska marknaden under den nya förordningen för in vitro-diagnostik (IVDR). Vi diskuterar den kritiska kopplingen mellan läkemedel och diagnostik, de nya klassificeringsreglerna som placerar de flesta CDx i en högre riskklass (Klass C), och de obligatoriska samrådsförfarandena med läkemedelsmyndigheter som Europeiska läkemedelsmyndigheten (EMA). Vi belyser även de skärpta kraven på klinisk evidens och varför en noggrann samordning mellan IVD-tillverkare och läkemedelspartner är avgörande för att undvika kostsamma förseningar.
- Vad är Companion Diagnosti...
2026-01-2803 min
चिकित्सा उपकरण वैश्विक बाजार पहुंचयूरोपीय IVDR के तहत साथी डायग्नोस्टिक्स (CDx): नियामक जटिलताएँ और बाजार पहुँचयह एपिसोड यूरोपीय इन विट्रो डायग्नोस्टिक रेगुलेशन (IVDR) के तहत साथी डायग्नोस्टिक्स (CDx) को बाजार में लाने की जटिलताओं पर केंद्रित है। हम दवा-डिवाइस समन्वय, अधिसूचित निकायों (Notified Bodies) के साथ परामर्श मार्गों, और सख्त नैदानिक साक्ष्य आवश्यकताओं जैसी प्रमुख चुनौतियों पर चर्चा करते हैं। यह एपिसोड निर्माताओं को यह समझने में मदद करेगा कि क्यों CDx को अक्सर उच्च-जोखिम वाली श्रेणियों में वर्गीकृत किया जाता है और फार्मा भागीदारों के साथ संरेखण उनकी बाजार पहुँच की समय-सीमा के लिए महत्वपूर्ण है।
प्रमुख सवाल:
- साथी डायग्नोस्टिक्स (Companion Diagnostics - CDx) क्या हैं और वे व्यक्तिगत दवा में क्या भूमिका निभाते हैं?
- यूरोपीय IVDR (Regulation EU 2017/746) ने CDx के लिए नियामक परिदृश्य को कैसे बदल दिया है?
- CDx विकास में फार्मास्युटिकल और डायग्नोस्टिक कंपनियों के बीच समन्वय इतना महत्वपूर्ण क्यों है?
- IVDR के तहत CDx के लिए आवश्यक नैदानिक प्रदर्शन और साक्ष्य (clinical evidence) के मानक क्या हैं?
- एक अधिसूचित निकाय (Notified Body) और एक दवा प्राधिकरण (medicines authority) के बीच परामर्श प्रक्रिया कैसे काम करती है?
- CDx उत्पादों को अक्सर कक्षा C या D जैसे उच्च-जोखिम वाले वर्गीकरणों में क्यों रखा जाता है?
Pure Global मेडिकल टेक्नोलॉजी (MedTech) और इन-विट्रो डायग्नोस्टिक (IVD) कंपनियों के लिए एंड-टू-एंड नियामक परामर्श समाधान प्रदान करता है, जो वैश्विक बाजार पहुँच को सुव्यवस्थित करने के लिए स्थानीय विशेषज्ञता को उन्नत AI और डेटा टूल के साथ जोड़ता है। हमारी सेवाएँ नियामक रणनीति विकसित करने, 30 से अधिक बाजारों में स्थानीय प्रतिनिधित्व प्रदान करने और AI का उपयोग करके तकनीकी डोजियर को कुशलतापूर्वक संकलित करने में मदद करती हैं। हम यह सुनिश्चित करते हैं कि आपका उत्पाद बाजार में आने के बाद भी अनुपालन में बना रहे। अधिक जानकारी के लिए https://pureglobal.com/ पर जाएँ, info@pureglobal.com पर संपर्क करें, या https://pureglobal.ai पर हमारे मुफ़्त AI टूल्स और डेटाबेस देखें।
2026-01-2803 min
الوصول العالمي إلى سوق الأجهزة الطبيةالامتثال للائحة IVDR الأوروبية: تحديات جديدة في تنظيم التشخيصات المصاحبة (CDx)تستكشف هذه الحلقة العقبات التنظيمية الكبيرة التي تواجه التشخيصات المصاحبة (CDx) بموجب لائحة الاتحاد الأوروبي للأجهزة الطبية التشخيصية في المختبر (IVDR). نحن نناقش التحول إلى تصنيفات المخاطر الأعلى، والارتباط المعقد بين الجهاز والدواء، وعملية التشاور الإلزامية مع سلطات الأدوية مثل وكالة الأدوية الأوروبية (EMA)، والمتطلبات المتزايدة للأدلة السريرية. تعلموا ما يجب على شركتكم القيام به لمواءمة الاستراتيجيات بين شركاء الأجهزة والأدوية لضمان الوصول الناجح إلى الأسواق.
- كيف غيرت لائحة (IVDR) تصنيف المخاطر للتشخيصات المصاحبة؟
- ما هي عملية التشاور الإلزامية بين الهيئة المُبلَّغة (Notified Body) وسلطة تنظيم الأدوية؟
- لماذا أصبح التنسيق المبكر مع الشريك الصيدلاني أكثر أهمية من أي وقت مضى لتطوير أجهزة (CDx)؟
- ما هي الأدلة السريرية الجديدة المطلوبة لإثبات أداء جهاز (CDx) بموجب لائحة (IVDR)؟
- كيف يؤثر الارتباط بين الدواء والجهاز على الجداول الزمنية لتقييم المطابقة؟
- ما هي الخطوات الاستراتيجية الرئيسية لتقديم ملف (CDx) ناجح في الاتحاد الأوروبي؟
تقدم Pure Global استشارات تنظيمية متكاملة لشركات التكنولوجيا الطبية (MedTech) والتشخيص المختبري (IVD). نحن نُبسّط الوصول إلى الأسواق العالمية من خلال الجمع بين الخبرة المحلية وأدوات الذكاء الاصطناعي والبيانات المتقدمة. يطور خبراؤنا استراتيجيات تنظيمية فعالة ويديرون تقديم الملفات الفنية للتوافق مع اللوائح المعقدة مثل (IVDR) في الاتحاد الأوروبي. سواء كنتم شركة ناشئة أو مؤسسة متعددة الجنسيات، فإننا نعمل كممثل محلي لكم في أكثر من 30 سوقًا، لضمان وصول منتجاتكم إلى الأسواق بشكل أسرع والحفاظ على الامتثال. للحصول على أدوات وقواعد بيانات مجانية تعمل بالذكاء الاصطناعي، تفضلوا بزيارة https://pureglobal.ai، أو تواصلوا معنا عبر info@pureglobal.com لمعرفة المزيد.
2026-01-2803 min
Wereldwijde Markttoegang voor Medische HulpmiddelenCompanion Diagnostics (CDx) en de IVDR: Een Gids voor Markttoegang in de EUDeze aflevering onderzoekt de ingrijpende impact van de EU In Vitro Diagnostic Regulation (IVDR) op Companion Diagnostics (CDx). We bespreken de verschuiving naar hogere risicoklassen, de cruciale noodzaak voor synchronisatie tussen farmaceutische en diagnostische partners, en de complexe conformiteitsroutes, inclusief de verplichte consultaties met autoriteiten zoals de EMA. Het is een essentiële gids voor elke fabrikant die de unieke uitdagingen van CDx-markttoegang in Europa wil begrijpen.
- Waarom worden Companion Diagnostics (CDx) nu als hoog-risico beschouwd onder de IVDR?
- Hoe beïnvloedt de IVDR de samenwerking tussen fabrikanten van diagnostica en farmaceutische bedrijven?
- Wat houdt de verplichte co...
2026-01-2703 min
Accesso Globale al Mercato dei Dispositivi MediciDiagnostici Companion (CDx) e IVDR: Strategie di Conformità per il Mercato UEQuesto episodio analizza le complessità normative per i diagnostici companion (CDx) ai sensi del Regolamento sui dispositivi medico-diagnostici in vitro (IVDR) dell'UE. Trattiamo la classificazione del rischio più elevata, i percorsi di consultazione obbligatori con le autorità farmaceutiche e i rigorosi requisiti di evidenza clinica che legano direttamente il dispositivo al farmaco corrispondente. Esploriamo come queste sfide impattino le tempistiche di immissione sul mercato e perché l'allineamento strategico tra i produttori di IVD e i partner farmaceutici sia cruciale per il successo.
- Perché i diagnostici companion (CDx) sono classificati a rischio più elevato sotto l'IVDR?
- Qual è il ruolo di un O...
2026-01-2703 min
Глобальный доступ на рынок медицинских изделийРегулирование Companion Diagnostics (CDx) в ЕС: Навигация по требованиям IVDR и консультациям с EMAВ этом эпизоде мы подробно рассматриваем регуляторные барьеры для сопутствующей диагностики (Companion Diagnostics, CDx) в рамках европейского Регламента по IVD (IVDR). Мы обсуждаем, как классификация рисков, обязательные консультации с лекарственными регуляторами, такими как EMA, и строгие требования к клиническим доказательствам усложняют процесс вывода этих продуктов на рынок. Основное внимание уделяется необходимости тесной координации между производителями диагностических тестов и фармацевтическими компаниями для успешного прохождения процедур оценки соответствия.
Ключевые вопросы:
- Почему Регламент IVDR создает особые сложности для сопутствующей диагностики (CDx)?
- Какова роль уполномоченных органов и лекарственных регуляторов в процессе сертификации CDx?
- Какие требования к клиническим доказательствам предъявляются для подтверждения связи между тестом и препаратом?
- Как синхронизировать регуляторные стратегии производителя IVD и фармацевтического партнера?
- С какими основными рисками сталкиваются компании при выводе CDx на рынок ЕС?
- Что такое процедура научной консультации и как она влияет на сроки?
Pure Global предлагает комплексные регуляторные решения для компаний, работающих в сфере MedTech и IVD, помогая ускорить доступ на мировые рынки. Наша команда экспертов разрабатывает эффективные стратегии для получения разрешений, включая сложные продукты, такие как сопутствующая диагностика (CDx) в рамках IVDR. Мы используем передовые инструменты на базе ИИ для оптимизации подготовки технической документации и управления ею. Свяжитесь с нами по адресу info@pureglobal.com или посетите наш сайт https://pureglobal.com, чтобы узнать, как мы можем поддержать ваш проект. Ознакомьтесь с нашими бесплатными ИИ-инструментами и базой данных на https://pureglobal.ai.
2026-01-2703 min
Acesso Global ao Mercado de Dispositivos MédicosDiagnósticos de Acompanhamento (CDx) na Europa: Navegando as Complexidades do IVDRNeste episódio, exploramos os desafios regulatórios para os diagnósticos de acompanhamento (Companion Diagnostics - CDx) sob o IVDR da União Europeia. Discutimos como a nova classificação de risco mais elevada (Classe C/D), a avaliação obrigatória por Organismos Notificados e o novo processo de consulta com autoridades de medicamentos, como a EMA, criam um caminho complexo para o acesso ao mercado. O ponto principal é a necessidade crítica de uma coordenação rigorosa e precoce entre os fabricantes de diagnósticos e os seus parceiros farmacêuticos para alinhar os cronogramas de desenvolvimento e a geração de...
2026-01-2703 min
Accès au Marché Mondial des Dispositifs MédicauxStratégies de Marquage CE pour les Diagnostics Compagnons (CDx) sous l'IVDR en EuropeCet épisode explore les défis réglementaires liés à l'obtention du marquage CE pour les diagnostics compagnons (CDx) dans le cadre du règlement européen IVDR (UE) 2017/746). Nous analysons l'impact de la classification des risques plus élevés, le processus de consultation obligatoire avec les autorités médicamenteuses comme l'EMA, et la nécessité cruciale d'une coordination étroite entre les fabricants de diagnostics et leurs partenaires pharmaceutiques pour garantir un accès au marché réussi.
- Qu'est-ce qu'un diagnostic compagnon (CDx) et quel est son rôle dans la médecine de précision ?
- Comment le règlement IVDR a...
2026-01-2703 min
Medicine Made SimpleMolecular Diagnostics: The Key in Personalized Cancer MedicineA comprehensive overview of molecular diagnostics and their crucial role in advancing personalized cancer medicine. The texts primarily discuss the development and validation of various predictive and prognostic biomarkers, particularly focusing on immunohistochemistry (IHC) and in situ hybridization (ISH) techniques for detecting genetic alterations like HER2 overexpression and gene amplifications. Significant attention is given to the analytical and clinical validation processes required for these assays, including the challenges of assay standardization, pre-analytical variables like tissue fixation, and regulatory pathways for co-developing drugs and companion diagnostics (CDx), such as with the example of trastuzumab and HercepTest™. Finally, the sources explore cl...
2025-11-2514 min
Conversations from LSIMission Possible: Disrupting Clinical Workflows | LSI Europe '25This Panel took place at LSI Europe ‘25 Emerging Medtech Summit in London.Industry leaders from Stanford Biodesign, May Health, Tensive, CDX Medical Technologies, and Nostics discuss strategies for successfully transforming clinical workflows, sharing insights on overcoming resistance to change in healthcare settings.This Panel featured:Josh Makower — Stanford BiodesignColby Holtshouse — May HealthSanjay Kakkar — TensiveGopal Chopra — CDX Medical TechnologiesEva Rennen — NosticsJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summ...
2025-11-1339 min
Digital-Pathology-TodaySeptember 2025 Digital Pathology RoundupDigital Pathology Roundup – September 2025
Funding:
Cyted Health raised €44m Series B led by EQT Life Sciences with Advent Life Sciences and British Business Bank; existing investors Morningside and BGF joined. Funds will drive US expansion, strengthen UK commercialization, and broaden tests beyond EndoSign, its minimally invasive oesophageal cell collection paired with advanced biomarker assays.
StratifAI closed €12.5m led by Picus Capital with Alven and others to clinically validate Polaris, a multimodal AI platform that fuses H&E histology, RNA-seq, and outcomes to generate prognostic and predictive spatial insights.
Regulatory Approvals:
Aiforia obtained CE-IVD for an AI tool detecting lymph node metast...
2025-11-0112 min
BMX Crypto Podcast | Web3, DeFi & Onchain InsightsTransforming Crypto Perps Trading with AI: Insights from Cod3x ($CDX) and Justin BebisExplore how AI-powered perpetuals trading agents are transforming cryptocurrency, DeFi, and Web3. In this episode, we sit down with Justin Bebis, founder of Cod3x ($CDX), to discuss how onchain AI is unlocking a new era of intelligent trading for crypto perpetuals.
Hosts Rachel Onchain and Deez dig into Justin's journey from DeFi experiments to building one of the first fully automated AI trading terminals. With Big Tony, Cod3x’s flagship AI agent, already showing the power of automation, the team now aims to make pro-level crypto trading accessible to everyone.
We cover:
...
2025-09-251h 01Digital-Pathology-TodayJuly 2025 Digital Pathology RoundupHere is the July 2025 Digital Pathology Roundup with Imogen Fitt of Signify Research.
Partnerships:
Owkin launched a 5-year partnership with Newcastle Upon Tyne Hospitals NHS Foundation Trust to apply agentic AI across drug discovery, development, and diagnostics. First up: an AI tool to screen for gBRCA mutations in breast cancer, with Newcastle running validation studies and contributing multimodal data via Owkin’s ATLANTIS network (20 institutions across 7 countries, 11 therapeutic areas.
Lunit teamed with Microsoft to broaden access to cancer-detection AI through Azure-based model fine-tuning and agentic workflow tools; this follows Lunit’s growing DP footprint (e.g., SCOPE PD-L1 TPS integrating with...
2025-08-2912 minDigital-Pathology-TodayJune 2025 Digital Pathology roundupThe June Digital Pathology Roundup with Imogen Fitt of Signify research is here.
Funding:
• RainPath AI raised €2.5M from Teampact.ventures, Xplore by Épopée Gestion, The Quest, Advance Lab, SHARPSTONE, about 15 angels, and Bpifrance. RainPath builds AI tools for virtual staining, smarter slide analysis, and structured reporting to cut reagent use and ease diagnostic bottlenecks. Funds will double headcount and advance product development and clinical validation.
• PreciseDx closed $11M led by Eventide, Merck GHI, and Philips Ventures, with Labcorp, Quest, GenHenn, and others. Eric Converse was named CEO and Ed Sitar CFO. Proceeds support more clinical data, commercial expansion, and prep...
2025-07-3112 min
Gig SoapJaron Bell | Authenticity Breeds FreedomsummaryIn this episode of the Gig So podcast, Chad Bourquin and Jaron Bell discuss Jaron's journey in the music industry, his recent distribution deal, and the importance of authenticity in artistry. They explore how social media has transformed the way artists connect with their audience, the challenges of balancing personal faith with a career in entertainment, and the significance of humor in performance. Jaron shares insights on creating viral content, building a brand, and offers advice for aspiring artists looking to make their mark in the industry.takeawaysJaron...
2025-07-1456 min
Getting Real with Jon & BethJoe Kelly: “Turkey Pot Pie”Nashville music mogul Joe Kelly joins the podcast for an insightful conversation about his journey to becoming President of CDX Nashville and CDX Records. Joe has been in the music business for 40 years and has
changed his strategies to coincide with the changes in the times of the
ever-changing music industry. He discusses why he chose not to meet his
musical hero, Merle Haggard, and the struggles he overcame in becoming
one of music’s most successful music distributors and radio chart
publishers. Hear how a turkey pot pie encouraged him to never give up
and why he loves the...
2025-05-1953 min
谭勇品读医药风云解码康弘药业业绩稳健的驱动力(下）康弘药业始终坚持创新战略，以眼科、精神神经、肿瘤三大核心治疗领域为主线，持续加大研发投入。随着去年4月FDA的一纸批文，全球眼科创新的目光聚焦至康弘药业，其自主研发的KH658基因治疗药物获准开展用于治疗新生血管性（湿性）年龄相关性黄斑变性的临床试验，这是康弘药业继KH631之后，第二款进入中美双报阶段的AAV基因疗法。目前，KH631已进入Ⅱ期临床试验阶段，KH658Ⅰ期临床试验正稳步推进。这些阶段性成果的背后，是一场关乎技术路线的生死竞速。与传统抗VEGF药物“治标不治本”不同，基因治疗通过AAV病毒载体将治疗基因导入视网膜细胞，使患者自体持续表达抗VEGF蛋白，理论上可实现“一次治疗 终生有效”。其中，在解决载体递送效率、免疫原性及长期安全性等问题，康弘采用AAV载体优化设计，降低免疫反应风险，同时采用差异化给药途径（如脉络膜上腔注射），具有给药方式简便、安全、转导细胞效率高的特点。放眼全球，康弘药业与艾伯维合作的在研基因疗法已进入美国临床Ⅲ期阶段。华福证券研报指出，若2025年关键临床数据积极，康弘有望成为全球第三家获批眼底病基因治疗的企业，占得千亿级市场先机。如果说基因治疗是康弘的未来引擎，那么KH815的横空出世，则让全球看到了中国药企在ADC领域的颠覆创新。2025年4月16日，CDE官网最新公示，康弘药业全资子公司康弘生物申报的I类新药注射用KH815获批临床，拟开发治疗晚期实体瘤。这是康弘生物研发的一种具有抗耐药潜力的靶向滋养层细胞表面抗原2的新型双载荷抗体偶联药物。该产品于今年3月在澳大利亚获批I期临床研究。体内药效研究显示，KH815在多个瘤种的CDX模型和PDX模型中均表现出剂量依赖的抑制肿瘤生长作用，并且在多个喜树碱类ADC耐药的CDX和PDX模型中也显示出抗肿瘤作用。曾有人将双载荷ADC比作是一款未来的“核武器”：双载荷不是简单的1+1，而是要像交响乐队的指挥家一样，让两种毒素在时空上精准协同。而这背后，是康弘对ADC技术路线的深刻洞察。华福证券测算，若KH815后续顺利上市，首年销售额有望突破15亿元，带动公司估值重塑。整体而言，康弘药业在2024年交上了一份令人满意的答卷。其营收业绩和利润的稳健增长，得益于生物药、中药等各业务板块的协同发展。而在创新战略的驱动下，丰富的在研管线为公司的未来发展奠定了坚实基础。站在2025年的十字路口，康弘的航道上并非全是风平浪静。基因治疗与双载荷的前景尚未可知，目前全球尚无眼底病基因治疗产品获批上市。在创新药研发“高风险高回报”的丛林法则下，在未被满足的临床需求领域，敢为人先者方有定价权。当然，“丛林竞争”固然激烈，不过凭借着强大的创新实力、优质的产品管线以及稳健的经营策略，康弘药业有望在未来的市场竞争中继续保持领先地位，为患者带来更多新的治疗选择。
2025-05-1205 min
Dividend StockpileCDX: Simplify High Yield ETF | Interview with Portfolio Manager Michael GreenSimplify Asset Management's Michael Green, Portfolio Manager and Chief Strategist, joins us to discuss the benefits of CDX - Simplify High Yield ETF. Michael has decades of investing experience and he shares his knowledge on topics such as the current state of the market, the dilemma of passive vs. active management, how regular dividends and synthetic dividends work and differ, and a deep dive on one of Simplify's high yield ETFs.Timestamps:00:00 Intro00:37 Welcome Michael Green from Simplify Asset Management00:58 Michael's background01:40 Intro to Simplify Asset Management03:12 Thoughts on the stock market today10:00 Passive vs. Active Management14:15 Benefits of...
2025-04-1736 min
今日美股(3/29)高收益债创新低，投资级利差走宽：债券市场嗅到风险味儿了？大家好，我是晓晨，欢迎收听今天的财经播客。今天是2025年3月29日，早上9点43分，咱们得聊聊周五，也就是3月28日，北美债券市场的小风波。Markit CDX北美高收益指数跌了0.6%，收在105.14点，经调整后创下2024年8月以来的新低。另一边，投资级债券利差指标涨了0.02个百分点，报61.2个基点，经调整后创逾两周新高。这俩数据一冷一热，市场风向有点扑朔迷离，咱们得掰开揉碎了好好说说。先看这Markit CDX北美高收益指数，跌0.6%到105.14点听着不多，可“经调整后2024年8月以来新低”这话可不轻。这指数追踪的是北美100家高收益企业的信用违约掉期（CDS），简单说，就是市场对这些垃圾债违约风险的定价。跌到105.14，说明啥？说明投资者对高收益债的信心有点动摇，风险溢价在走高。你想啊，这指数去年8月还稳在110点上方，现在一路滑下来，背后肯定有故事。周五的数据一出，X上有人直呼，“高收益市场这是要凉啊？”我看没那么夸张，但确实有点凉风吹过。原因不难猜，美国2月核心PCE物价指数2.8%，通胀压着美联储不放手，利率还得硬挺在4.25%-4.5%，企业借债成本高企，高收益债自然不好过。再看投资级债券利差，涨0.02个百分点到61.2个基点，别小看这零点几个点，调整后可是两周多的新高。这利差是投资级债券收益率跟美国国债的差距，61.2个基点意味着市场对这些“优质”企业的信用风险也在重新定价。正常来说，投资级债券是避风港，可现在利差走宽，说明投资者连这些靠谱家伙都不太放心了。周五美债10年期收益率还摸到4.35%，国债价格跌、收益率涨，债券市场整体压力不小。X上有交易员吐槽，“美联储不降息，债券市场全线吃紧。”这话有点道理，高利率环境把资金都挤到避险资产去了，黄金周五冲到3086.82美元就是明证。这俩指标一跌一涨，其实透着同一个信号——市场情绪在转谨慎。高收益指数跌，说明垃圾债的风险溢价上升，企业违约的担忧加剧；投资级利差涨，说明连优质债券都得付出更高成本吸引买家。背后推手，除了美联储的鹰派姿态，还有特朗普关税这把悬剑。关税战一开，全球供应链乱套，美国企业利润被压缩，高收益企业首当其冲。投资级企业虽然抗风险强点，可也得面对融资成本上升的现实。摩根士丹利前两天还说，美国经济可能放缓，这话跟周五的个人支出数据一呼应，市场更慌了。当然，也别太悲观。高收益指数105.14虽然低，可还没到2022年那会儿100点以下的恐慌水平；投资级利差61.2个基点，离历史高点120基点还远着呢。短期看，这波调整可能是市场消化数据后的正常反应。黄金、白银、美元都在动，说明资金还没彻底撤退，只是在换阵地。X上有人猜，“高收益债跌多了，抄底的机会要来了。”这话有点道理，跌到一定程度，收益率高得诱人，机构没准会回场捡便宜。对咱们投资者来说，这信号挺明确。短期内，高收益债得悠着点，波动风险不小；投资级债券可以瞅瞅，但别指望大赚，利差走宽可能是买入时机。避险资产像黄金、日元还能再关注关注，市场这池水浑着呢，得稳住阵脚。好了，今天就聊到这儿。如果觉得晓晨聊得有点意思，记得关注我，点个赞支持一下。以上纯属个人瞎侃，仅供参考，别拿它当投资指南，盈亏自负。市场无情，咱们得悠着点。感谢收听，下期见！
2025-03-2904 min
Roger the Wild Child ShowNashville: Billie Jo Jones & Bryan RubyOn this episode of Roger the Wild Child Show: Nashville edition, we are joined country music artist, Billie Jo Jones, and singer/songwriter, Bryan Ruby!BILLIE JO JONES“Lifelong Texan Billie Jo Jones is being heard all over the world. Her previous single "Right Now Kinda Girl" hit #1 on the Texas Regional Radio Chart, 2 weeks in a row on CDX True Indie & several weeks in a row on Texas Internet Radio Chart. The news is spreading fast about this spitfire blonde headed Texan who is resurrecting her favorite style of country music. Hard hitting and tr...
2024-10-031h 04
Handeln. Der Podcast der Otto Group.Ohne Firlefanz – mit Kulturwandel zur performanten OrganisationSeit sieben Jahren gibt es die #CDX, die Cultural Development Experience, als Veranstaltung für alle, die sich mit Kulturwandel und Change-Management beschäftigen. Und noch immer gibt es großen Bedarf für das gemeinsame Lernen und den Erfahrungsaustausch. Der Kulturwandel ist in der Otto Group schon 2015 gestartet, doch ein Ende ist nicht in Sicht – kann es auch gar nicht, da die kulturelle Transformation ein kontinuierlicher Prozess ist, der in Zeiten von Multikrisen relevanter denn je ist. Das Gute ist: Alle Organisationen stehen vor ähnlichen Herausforderungen. Und wer fleißig übt, zum Beispiel mutige Entscheidungen zu treffen, transparent zu kommunizi...
2024-07-0124 min
Wired to BuildDriving Construction Progress With Common DataEpisode Summary
In this episode, Nick Caravella and Avi Levin celebrates Avicado Construction Technology Services' ninth birthday and discusses the milestones achieved over the years. They are joined by Nathan Wood, the Executive Director of the Construction Progress Coalition, who shares his journey and the formation of the coalition.
The conversation delves into the importance of real-time data and the need for a common data exchange framework. Listeners will learn about the challenges of data standards and the value of tagging and categorizing information.
The conversation covers subjects such as project health, sustainability, design thinking...
2024-03-2854 min
2023-05-1540 min
The Curds of Wisdom PodcastKyle and James Throwdown Plus LIVE FROM CDX!Send us a textKyle and James get into it over using local judges. This episode includes our two pieces from the lives shows from CDX. We have merchandise! Check out our FB page.Trying Our Quest: A D&D Improv Comedy Actual-Play PodcastAn actual-play D&D comedy podcast hosted by some of New York’s most...Listen on: Apple Podcasts Spotify
2023-05-021h 15
The Crude TruthTHE CRUDE TRUTH Ep 21 Nicholas Rodriguez CEO of CDX Energy Services and Breanna JohnsonIf you have not heard of CDX Energy Services you have to check them out, They offer a broad range of services that will help maximize your operations. On this episode, we sit down with the CEO, Nick Rodriguez to discuss how CDX Energy is helping keep the environment safe in the oil and gas industry. We also talk with his Business Development Manager Breanna Johnson and what all she has going on in Midland Texas!Sponsorships are available or get your own corporate brand produced by Sandstone Media. David Bla...
2023-03-2041 min
Laboratory Considerations for Clinical TrialsFlow Cytometry as an IVD technology for Companion DiagnosticsIn this episode, Megan McCausland, Scientific Advisor for Flow Cytometry at Q2 Solutions, and Scott Bornheimer, Associate Director of Medical and Scientific Affairs at BD Biosciences talk about the enormous potential of flow cytometry as a clinical diagnostic tool.
Currently, pharma companies are looking for simplified, standardized flow cytometry tests to help with enrolling patients and understanding outcomes in their studies.
In the longer term, Megan McCausland notes what will lead to the use of flow as a CDx:
“I think the drug development landscape really continues to evolve towards more personalized medicine. As t...
2022-11-3020 min
Texas Toast91. JOE KELLY of CDX NashvilleSend us a text and let us know what you think!Joe Kelly from CDX Nashville joins the podcast today to fill us in on the integral role CDX has been playing in in Country music for over two decades. Find out more about their charts and radio distribution services on today's epsiode!Learn more about CDX at https://cdxcd.comYou can support Texas Toast by following us on social medias (@texastoastpod), giving a 5-star review on Apple Podcasts and Spotify, subscribing on YouTube and MOST IMPORTANTLY, sharing the show with a...
2022-11-2931 min
Inglorious Globastards - PODCASTIl Bunga Bunga 2.0 al SenatoLa notizia che Berlusconi intende candidarsi al Senato e la promessa ottenuta da Salvini di diventarne il Presidente forniscono un'anticipazione abbastanza esilarante sul tenore della prossima campagna elettorale.Ma i sondaggi che danno in testa il centrodestra devono poi essere calati in una realtà dove per ottenere la maggioranza al Senato bisogna ottenere un risultato molto robusto nei 74 collegi uninominali.Ciascun senatore dovrà battersi in un collegio che rappresenta circa un milione di residenti e quindi la qualità dei candidati. Roberto D'Alimonte si è fatto due conti e li ha pubblicati il 23 luglio in un arti...
2022-07-3138 min
Making MedTech Happen with RQM+Live! #58 –Regulatory Landscape of Companion Diagnostics (CDx) in the EUThis is audio from RQM+ Live! #58, recorded 14 July, 2022. To join us live for future shows and ask your own questions, please view and sign up for upcoming events in the Knowledge Center at our website.
Companion diagnostics (CDx) are critical to patient safety when taking potentially life-saving drugs, e.g. in oncology. CDx can help identify which patients will benefit from a specific drug treatment to improve patient outcomes and identify those patients who have an increased risk for serious side effects from a certain treatment. Hence, CDx are essential in the evolution of precision medicine “providing th...
2022-07-151h 07
Altri podcastElezioni Lucca: il commento di Mario Pardini (cdx)Sostenuto da Fratelli d’Italia, Forza Italia-unione di Centro, Lega Salvini premier e la lista Mario Pardini sindaco, il candidato del centro destra va al ballottaggio con il 34,35% dei consensi
Continue reading Elezioni Lucca: il commento di Mario Pardini (cdx) at www.controradio.it.
2022-06-1402 min
The Contracting ExperienceThe Contracting Experience - Episode 34: Accelerating Commander’s Initiatives – Kimberly Norman and Barbaralee Mariano KelleherThis episode features Air Force Materiel Command's Commander's Initiatives Group Director Kimberly Norman, and Procurement Analyst Barbaralee Mariano Kelleher, who discuss the AFMC CDX office and how it is accelerating innovation initiatives. They talk about what CDX’s mission is and the progress that has been made through the AFMC We Need initiative. In addition, the ladies share how the AFMC workforce can engage with CDX to get additional resources and help solve problems out in the field.
Acronyms:
AFMC – Air Force Materiel Command
If you would like to share feedback on the podcast, please submit via thecontractingexperience@gmail.com.
Regi...
2022-01-1824 min
PreMarket PrepVirgin Galactic To The Moon? Earnings & IPOs To Watch This Week | July 12, 2021On Today's PreMarket Prep:
- Virgin Galactic To The Moon?
- Reopening stocks to buy
- IPOs to watch this week
Mover of this morning: $CLDX
Celldex Therapeutics shares are trading higher after the company reported data from its CDX-0159 Phase 1b study in chronic inducible urticaria. See Related Article on Benzinga.com https://www.benzinga.com/wiim/21/07/21933923/celldex-therapeutics-shares-are-trading-higher-after-the-company-reported-data-from-its-cdx-0159-pha
FEATURED GUESTS:
Tim Quast, Market Structure Edge 34:00
Twitter: https://twitter.com/_timquast
Matt Hammond, IPOWarriors 63:00
https://www.Ipowarriors.com
Twitter: https://twitter.com/warrioripo
MEET THE HOSTS:
Dennis Dick
Twitter: https://twitter.com/TripleDTrader
Joel Elconin
Twitter: https://twitter.com...
2021-07-121h 30
The Health+Wealth Of AmericaTrailer: The Health+Wealth Of America A Limited SeriesJoin Techonomy, CDX, and Worth as we explore the state of the U.S. as it emerges from the pandemic and a painful prolonged economic crisis in a limited podcast series - The Health+Wealth of America. Where do we stand with the vaccine and recovery from COVID? What's next for healthcare innovation? How is capitalism and our economy doing in this stressful time?
2021-04-3001 minThe Health+Wealth Of AmericaHow Technology can Help to Advance Health Equity with Jim SwansonThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Jim Swanson, Johnson & Johnson, EVP & Enterprise CIO, is a visionary IT leader with 30 years of experience helping companies excel in the digital space through the adoption of cutting-edge technologies and structures speaks with Josh Kampel, CEO of Clarim Media.
2021-04-3021 minThe Health+Wealth Of AmericaHow Tech and Data Can Diversify Networks with Asmau AhmedThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Asmau Ahmed, Banking executive and founder of Diversity Meter. Asmau believes in humanizing technology and utilizing its pervasiveness for superior business outcomes and better people decisions speak with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media.
2021-04-3023 minThe Health+Wealth Of AmericaNature+Tech=Sustainable Fashion with Amanda ParkesThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Amanda Parkes, Chief Innovation Officer at PANGAIA. Dr. Parkes. is a fashion scientist focused on fashion innovation, sustainability, wearable technology, interaction design and smart materials spanning research, development, and product commercialization for start-ups and major tech and fashion companies speaks with Robin Raskin, Founder of Virtual Events Group and Techonomy Contributor.
2021-04-3030 minThe Health+Wealth Of AmericaWhat Does it Mean to Make a Company "Just"? with Christoph SchellThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Christoph Schell, Chief Commercial Officer HP Inc. accountable for customer success globally speaks with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media
2021-04-3020 minThe Health+Wealth Of AmericaHow America Bungled the COVID Pandemic with Nina BurleighThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Nina Burleigh, Author + Journalist. Nina is an award-winning author, journalist, lecturer and feminist cultural critic who speaks with James Ledbetter, Chief Content Officer of Clarim Media and Founder of Fin.
2021-04-3023 minThe Health+Wealth Of AmericaHow Data Can Help Stop Future Pandemics with Bret GreensteinThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Bret Greenstein, SVP and Global Head of AI & Analytics Cognizant who leads Cognizant’s Global Data Practice, focused on helping Chief Data Officers transform their businesses through Data Modernization speaks with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media.
2021-04-3023 minThe Health+Wealth Of AmericaDemocratizing Access to Personal Wellness with Mindy GrossmanThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Mindy Grossman, President and CEO of WW (Formerly Weight Watchers) a disruptive leader known for building and transforming consumer brands speaks with Josh Kampel, CEO of Clarim Media.
2021-04-3020 minThe Health+Wealth Of AmericaIs the U.S. Finally Spending What We Should? with Joseph StiglitzThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Joseph Stiglitz, Economist + Nobel Laureate speaks with James Ledbetter, Chief Content Officer of Clarim Media and Founder of Fin.
2021-04-3033 minThe Health+Wealth Of AmericaWhy The Future Depends on Investing in Talented People with Eric BravermanThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Eric Braverman, Schmidt Futures. Eric Braverman who is the chief executive of Schmidt Futures speaks with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media.
2021-04-3021 min
The Health+Wealth Of AmericaWhat Does “Work-Life Balance” Mean Now? with Daisy DowlingThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Daisy Dowling, is an executive coach, full-time working parent to two young children, and author of WORKPARENT: The Complete Guide to Succeeding on the Job, Staying True to Yourself, and Raising Happy Kids speaks with Caitlin Hamilton, Director of Executive Relations and Techonomy Contributor.
2021-04-3017 min
The Health+Wealth Of AmericaHalf Price Healthcare That’s Twice as Good with Johnathan BushThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Jonathan Bush, Executive Chairman of Firefly Health speaks David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media
2021-04-3019 min
The Health+Wealth Of AmericaWill America’s System Win the Global Ideological Battle? with Dambisa MoyoThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Dambisa Moyo, Economist + Author, Dr. Moyo is a pre-eminent thinker, who influences key decision-makers in strategic investment and public policy speaks with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media.
2021-04-3026 min
The Health+Wealth Of AmericaCan American Democracy Survive? with Michael TomaskyThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Michael Tomasky, of The New Republic. Michael Tomasky Author and Top Editor The New Republic speaks with James Ledbetter, Chief Content Officer of Clarim Media and Founder of Fin.
2021-04-3027 min
The Health+Wealth Of AmericaDigital Transformation: a Healthcare Imperative with Jackie KentThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Jackie Kent EVP, Chief Customer Officer Medidata speaks with Jennifer Gottlieb, Global President of Real Chemistry.
2021-04-3018 min
The Health+Wealth Of AmericaThe Pandemic Accelerated Life Sciences – What Next? With Dr. Eric TopolThe Health+Wealth of America is a series of conversations hosted by CDX, Techonomy and Worth about challenges and opportunities facing our country. In this episode, Dr. Eric Topol, Scripps Institute speaks with David Kirkpatrick, Founder & Editor-in-Chief, Techonomy Media.
2021-04-3024 min
杨扬侃车20210420——盘点上海车展那些吸引人眼球的新车大家好，我是凯文，今天的节目依然是采用了山东交通广播线上及视频直播以及‘杨扬侃车’抖音号视频直播多媒体呈现方式，热线和网络上的朋友买车选车的问题依然不少，来看今天的内容概要：盘点上海车展上那些吸引人眼球的新车：欧拉朋克猫跟大众经典的甲壳虫有着非常高的相似度，让我们仿佛穿越回上世纪五六十年代一般。 / 皇冠威尔法可能有平价销售的可能，似乎还是埃尔法更被认可。 / 上汽大众正式全球首发了全新途昂家族，全新途昂X凭借更运动的外观设计，成为了旗舰豪华运动SUV。 / 一汽-大众在本届车展上首次发布了国产第八代高尔夫 GTI 车型 / 广汽讴歌CDX尊享智能安全版、CDX尊享·A-Spec智能安全运动款车型正式上市，售价为26.98-27.58万元。等等更多问题，收听节目留言即可~
2021-04-2048 min
杨扬侃车20210419——上海车展全新汉兰达等热门车型盘点大家好，我是凯文，今天的节目依然是采用了山东交通广播线上及视频直播以及‘杨扬侃车’抖音号视频直播多媒体呈现方式，热线和网络上的朋友买车选车的问题依然不少，来看今天的内容概要：1.全新一代汉兰达的前格栅造型与现款车型有所区别，上窄下宽的类梯形前格栅搭配熏黑中网以及飞翼式镀铬，增强了前脸的气势和设计感。前大灯依旧采用细长设计，让前脸整体看起来造型感十足。/ 广汽讴歌CDX尊享智能安全版、CDX尊享·A-Spec智能安全运动款车型正式上市，售价为26.98-27.58万元。/ 马自达CX-5黑骑士特别版正式上市，新车共推出3款车型，售价区间为20.18-23.58万元。 / 一汽丰田RAV4荣放双擎E+正式上市，共推出3款车型，补贴后售价区间为24.88-29.68万元。 / MINI家族正式上市，新车共推出17款车型，其中新款MINI三门版7款，售价为19.88万起2.连线身在上海车展的前方主持人杨扬盘点上市新车。更多问题，收听节目留言即可~
2021-04-1948 min
Leaders in Tech and Ecommerce#41: Adam Compain Founder & CEO of ClearMetalAdam Compain is the Founder & CEO of ClearMetal. Prior to ClearMetal, Adam spent 5 years at Google launching their geoCommerce technology and 19 years as the Executive Director of SEND, the nonprofit he founded. Adam holds five technology patents, two degrees from the University of Michigan, and an MBA from Stanford.ClearMetal, Inc., based in San Francisco, CA (USA), is a leader in the Continuous Delivery Experience (CDX), enabling supply chain organizations to optimize logistics and provide their customers with easy access to trusted, live information about their shipments and a customer experience that is a differentiator and revenue...
2020-09-2938 min
2020-06-2806 min
CannMed Coffee TalkEvaluating Cannabis Testing Methods with Brianna Cassidy, PhDOn the latest episode of CannMed Coffee Talk, we welcome Brianna Cassidy, Chief Science Officer of CDX Analytics.
Brianna and the team at CDX perform safety testing on all types of cannabis samples, including potency, pesticides, heavy metals, residual solvents, and microbial contamination. As you will hear in the podcast, Brianna takes a creative and analytical approach to solving problems that come with testing cannabis products. At CannMed 2020, Brianna will share her process for evaluating new analytical methods and technologies for her lab. As you can imagine, there are a number of vendors looking to install their...
2020-06-2400 min
TMI with Kevin RyanDigital Networking, CDX, and Audience Customization with Drew Ianni of CDXDrew Ianni, Founder, and Chairman of CDX, a conference series for senior digital executives, joins the show this week. Drew and Kevin discuss the merge into the Techonomy family and suggestions as to how we can best adjust to networking digitally for the time being. Drew also shares examples of speakers that connected to the audience and moved them with their words and messages, and also moments that didn’t go to plan, and the lessons learned. He also mentions what we can expect from the virtual conference in June, and ways to take advantage of the editorial content th...
2020-05-0639 min
State of the Music BusinessState of the Music Business Episode #1 with Guest Joe Kelly from CDX NashvilleWe are excited to bring you a new segment of "The Chris & Sandy Show" called "State of the Music Business. We will bring on top executices from the music business side for them to share where they been, where they are going and where they feel the music business is headed into the future!We are excited to have as our first guest Joe Kelly from CDX Nashville!
2020-01-3048 min
The Chris & Sandy ShowState of the Music Business Episode #1 with Guest Joe Kelly from CDX NashvilleWe are excited to bring you a new segment of "The Chris & Sandy Show" called "State of the Music Business. We will bring on top executives from the music business side for them to share where they been, where they are going and where they feel the music business is headed into the future!We are excited to have as our first guest Joe Kelly from CDX Nashville!
2020-01-3048 min
RapolitikCDX / 17 \ RapolitikAujourd'hui nous accueillons le quart du groupe légendaire Double Shots ainsi membre du groupe notoire 45 Starz, CDX. Sans rallumer de flamme du passé, les historiens du hip-hop québécois ont révisé les moments clés du groupe afin d'éduquer les nouveaux arrivants du hip-hop québécois et rafraîchir la mémoire de ceux qui sont là depuis début 2000. On avait beaucoup à revoir sur les faits historiques. Double Shots, Full ekwip, BBT, Negsayo; sont tous des groupes qui ont ouvert les portes pour les rappeurs d'aujourd'hui et il faut leur en être reconnaissant.Bonne écoute!
2019-10-231h 24
Flipping It The Reselling PodcastEp. 34 - Garage Sale Talks #8 - Sega CDX Console, Cisco Office Phones, PS4 Rock Band BundleOn Episode 34 I talk about what I was able to find at the garage sales this week. I found some big finds this week so I'm excited to see how they sell. If you could please rate and review the podcast that would mean a lot. Hope you enjoyed this weeks episode and as always Keep On Flipping!
New Episodes Every Tuesday
Apple Podcast: Flipping It
Find me on Instagram: @flippingit_
---
Support this podcast: https://podcasters.spotify.com/pod/show/flippingit/support
2019-08-1320 min
杨扬侃车20190409—制造业增值税下调3%车价下降；讴歌CDX是伪豪车么山东交通广播《购车联盟》20190409节目绿色版：1.制造业增值税下调3%，车价下降；2.名爵HS配合增值税下调官降明显，性价比突出；3.解答听众选车买车提问——丰田奕泽动力、油耗、维修保养怎样；日产骐达特点分析；欧兰德四驱7座vs科迪亚克7座谁可买性更强；2019款宝马3系优惠6万值得购买么；途安L保养注意事项；一年两万公里，家用买奇骏还是CRV混动；奔腾T77有何特点；途昂2.5T烧机油么，买高功率还是低功率划算；新CC VS奥迪A4L谁操控好、后期便宜；新款奥迪Q5是进步还是退步；亚洲龙VS林肯MKZ；倒车影像时好时坏什么鬼；吉利嘉际性价比高么、为什么用扭力梁后悬架、推荐购买哪一款；领克03型PRO动力操控性能保养如何；雷克萨斯UX是否值得购买；讴歌CDX是否是30万级别唯一用非独立后悬架的伪豪华车；荣放买老款还是新款，区别大么；
2019-04-1939 minLaboratory Considerations for Clinical TrialsSelection of Biomarkers for Immuno-Oncology - Patrice HugoDr. Patrice Hugo, Chief Scientific Advisor at Q2 Solutions discusses the selection and use of biomarkers in Immuno-oncology trials and the importance of early engagement between sponsors and clinical trial partners.
We are seeing that too often, in early phase clinical trials, drug developers for immuno-oncology investigation of products are considering bio-markers as true CDx or companion diagnostics; when in fact, they aim at producing information at a later stage, evaluating the potential of these bio-markers to be of CDx. At times the confusion here is adding a lot of pressure to the clinical labs to validate...
2019-02-0618 min
Healthy INSIDER PodcastSupplement OWL registry grows to 12,000 labels – podcastSince ideation two years ago, the Supplement OWL (Online Wellness Library) launched, and now includes over 12,000 labels and is guided by an advisory board to ensure it continuously meets industry needs. In addition, the Commercial Data Exchange (CDX) portion of the OWL, which helps retailers compare products, has become more robust. In this podcast, Gisele Atkinson, vice president, quality and technical affairs, Council for Responsible Nutrition (CRN), and Douglas “Duffy” MacKay, N.D., senior vice president, scientific and regulatory affairs, CRN, discuss the OWL’s progress and future. CRN spearheaded the industry-wide initiative. Atkinson and Duffy cover:
• The benefits of the Supp...
2019-01-3000 min
The Construction Shared Pains PodcastCDX Innovation Challenge - Transforming the Submittal ExchangeDigest - Why is there so much waste generated in the Submittal process? Debate - How technology streamline the submittal process without losing the value of their intent? Decide - Of these necessary changes to the process, what are the barriers in which we can control? What roadblocks exist externally that we cannot control? Deliver - How might a CDX Playbook help project teams communicate their unique workflow requirements through a common digital language? Guest Interviews: Brianna Halfhide, Clark Pacific Ian Coates, Autodesk, @IanCoates Ian Brown, Baronne S...
2018-11-0200 min
WE Have CancerJoe Mahaffey Is Working Hard to Honor His Brother's MemoryAfter his brother Doc's death in 2017 from colorectal cancer, Joe Mahaffey has assumed the role of passionate advocate. In March of 2018 Joe traveled to Washington, D.C., along with close to 200 fellow patients, survivors and caregivers, for Fight CRC's annual Call-On Congress. Back home in North Carolina Joe has been working to fulfill one of his brother's dreams; to have a colorectal cancer license plate available for North Carolina residents. The Blue Ribbon Warrior license plate is one of the focuses of the non-profit the Mahaffey brothers created, the Blue Ribbon Warrior Foundation. Lee also inte...
2018-05-2248 min
RGB Inside PodcastRGB Inside Podcast 09: Especial Mega Drive + Sega CD + 32XNono episódio do RGB Inside Podcast, o seu podcast quinzenal de retro games e crocância. Os apresentadores Alex Figueiredo, Fabio Michelin e Fabio Santana falam tudo sobre o Mega Drive e suas expansões: diferenças entre os modelos, acessórios e add-ons, mods possíveis, como extrair a melhor imagem e muito mais.
Baixe em MP3:
https://spaces.hightail.com/space/e7VnGH3OBl
Ouça no iTunes: https://itunes.apple.com/us/podcast/rgb-inside-podcast/id1318041313?mt=2
Assine o feed no Soundcloud: http://feeds.soundcloud.com/users/soundcloud:users:337102664/sounds.rss
TIMECODE:
0:00:31 Considerações sobre episódio anterior
0...
2018-03-1300 min
Crypto RichAtomic Swaps with Minexcoin!! Updates - INS, PPP, CDX, Propy, Caviar, Tokenpay and L-Pesa Atomic swaps with Minexcoin are coming! How much am I making daily with MNX? Plus updates from INS, Paypie, Commodity Ad Network, Propy, Caviar and L-Pesa
L-PESA
https://tinyurl.com/https-l-pesa-com-lcryptorich
https://web.telegram.org/#/im?p=s1399401730_5205128510394579883
INS
https://web.telegram.org/#/im?p=@ins_ecosystem
https://ins.world/
https://blog.ins.world/monthly-update-january-2018-1c96d569a2e7
PROPY
https://www.facebook.com/propyinc/
https://propy.com/
TOKENPAY
https://www.tokenpay.com/
https://medium.com/tokenpay/tokenpay-february-update-eefba7b65174
https://t.me/joinchat/GgZih0NrYt2F11oXwQ11Cg
CAVIAR
https://t.me/caviar0x
https://caviar.io/
MINEX
https...
2018-02-0325 min
Crypto RichUpdates on Electroneum, Spectre, INS, Paypie, CDX, & how to buy into Caviar ICO Please watch: "Don't get hacked! Keep your cryptos safe with this."
https://www.youtube.com/watch?v=KZzNTSB0tYs --~--
In this video, I demonstrate how to buy Caviar tokens. I announce some exciting news about Caviar, Spectre, Electroneum, INS, Paypie and Commodity Ad Network.
CAVIAR ICO - https://tokensale.caviar.io/?ref=5033
https://caviar.capital/
https://www.youtube.com/watch?v=HCotgkGzba4
https://www.youtube.com/watch?v=cZTz6cmtdSc
https://t.me/caviar0x
https://ins.world
https://blog.ins.world/unsold-ins-tokens-airdrop-d3ec05659e2a
https://www.facebook.com/electroneum
http://crypto-royalty-awards.d10e.biz/
https://next...
2018-01-1635 min
Crypto RichElectroneum Launches Today! Updates on Spectre, FLIP, Caviar.io, Paypie, CDX, and Minexcoin Please watch: "Don't get hacked! Keep your cryptos safe with this."
https://www.youtube.com/watch?v=KZzNTSB0tYs --~--
I give an update and info about Electroneum's launch as well as updates on Spectre.ai, FLIP, Caviar.io, Commodity Ad Network, Paypie, and I park some more Minexcoin
KEEP YOUR ETN! USE A VPN - 72% OFF - https://nordvpn.com/cryptorich
ELECTRONEUM PLAYLIST - https://www.youtube.com/watch?v=JZ8UfHG5vVw&list=PLz78JPp-ldyhKDq7TJhc8hoIX4AiaAlWZ
BUY AND SELL ELECTRONEUM HERE - http://tinyurl.com/Cryptopia-Cryptorich
ELECTRONEUM
https://trends.google.co.uk/trends/explore?date=2017...
2017-12-1325 min
Crypto RichTechnical Analysis - Afzal Ahmed - ETN, MNX, BTC, ADA, POWR, PPT, PPP, VERI & OMG Please watch: "Don't get hacked! Keep your cryptos safe with this."
https://www.youtube.com/watch?v=KZzNTSB0tYs --~--
Professional Trader, Afzal Ahmed carries out some technical analysis on some of the coins featured on this channel.
- NORD VPN - Use code for 72% off! - https://nordvpn.com/crypto
- AFZAL AHMED TRADING SERVICE
tradingwithafzal@gmail.com
https://www.facebook.com/afzal.ahmed83
BUY ELECTRONEUM HERE - http://tinyurl.com/Cryptopia-Cryptorich
BUY AND SELL MINEXCOIN, CDX AND OTHER CRYPTOS HERE -https://www.livecoin.net/?from=Livecoin-2ZM3dznk (CR)
BUY AND SELL POWR AND OTHER CRYPTOS HERE...
2017-12-0430 min
Crypto RichINS - Reducing the cost of food with blockchain Please watch: "Don't get hacked! Keep your cryptos safe with this."
https://www.youtube.com/watch?v=KZzNTSB0tYs --~--
In this video, I give a general overview of how the INS platform will disrupt the grocery supply chain.
INS ICO - https://tokensale.ins.world/?ref=53f95acf811227c6e40ea87b
INS
https://ins.world/#how_ins_works
https://ins.world/INS-ICO-OnePager.pdf
https://ins.world/INS-ICO-Presentation.pdf
https://ins.world/#documents
https://ins.world/INS-ICO-Whitepaper.pdf
https://tokensale.ins.world/distribution
https://t.me/ins_ecosystem
https://instamart.ru/
https://www.unilever.com/about/who-we-are/about-Unilever/
...
2017-11-2920 min
Crypto Rich750% in 23 days! Not a lending coin + News on ETCH, PPP, and CDX Please watch: "Don't get hacked! Keep your cryptos safe with this."
https://www.youtube.com/watch?v=KZzNTSB0tYs --~--
What coin has grown 750% in 23 days and is not a lending coin?
Plus latest news on Etch, Paypie and Commodity Ad Network
LINKS
GET MINEXCOIN HERE -
https://www.livecoin.net/?from=Livecoin-2ZM3dznk
https://medium.com/minecoin-blog/how-to-get-minexcoin-mnx-b4912999e43d
MINEXCOIN
https://minexcoin.com/
https://minexcoin.com/html/download/wpeng.pdf
https://minexcoin.com/?r=site/faq
https://medium.com/minecoin-blog
https://bitcointalk.org/index.php?topic=1847292.0
https://minexbank.com/index.php?r=site%2Fmemorandum
https://medium...
2017-11-2731 min
七车别克GL6、新英朗和新款普拉多申报，全新A8 Avant版本上汽通用别克GL6和新款英朗申报，讴歌将推CDX混动版车型，丰田新款普拉多亮相工信部，全新A8 Avant假想图「七车资讯丨0713讴歌CDX混动版」欢迎订阅！
2017-07-1302 min
七车别克GL6、新英朗和新款普拉多申报，全新A8 Avant版本上汽通用别克GL6和新款英朗申报，讴歌将推CDX混动版车型，丰田新款普拉多亮相工信部，全新A8 Avant假想图「七车资讯丨0713讴歌CDX混动版」欢迎订阅！
2017-07-1302 min
ZION NEWSIsrael Legalizes Illegally Built Homes In West Bank Outposts1. Air Raid Drill Held In Sharon Plain This MorningDrill for Israel's rocket alert system took place today in the ‘Sharon plain’ near Tel Aviv. The drill comes after yesterday’s attack on the south when a Palestinian rocket launched from Gaza struck Israel. #Drill #Sharon____________________2. Israel Legalizes Illegally Built Homes In West Bank OutpostsIsraeli Knesset passed the controversial settlement bill that retroactively legalizes about 4,000 settler homes that have reportedly been built on privately owned Palestinian land in the West Bank.#Knesset #SettlementBill____________________3. P.A. Condemns ‘Regulation’ Bill As A...
2017-02-1426 min
ZION NEWSIsrael Legalizes Illegally Built Homes In West Bank Outposts1. Air Raid Drill Held In Sharon Plain This MorningDrill for Israel's rocket alert system took place today in the ‘Sharon plain’ near Tel Aviv. The drill comes after yesterday’s attack on the south when a Palestinian rocket launched from Gaza struck Israel. #Drill #Sharon____________________2. Israel Legalizes Illegally Built Homes In West Bank OutpostsIsraeli Knesset passed the controversial settlement bill that retroactively legalizes about 4,000 settler homes that have reportedly been built on privately owned Palestinian land in the West Bank.#Knesset #SettlementBill____________________3. P.A. Condemns ‘Regulation’ Bill As A...
2017-02-0725 min
ams车评丨大咖说191期丨大咖说：凯迪拉克XT5对比奔驰GLC，应该怎么选？今日回答问题撸迅：XT5，28t豪华四驱对比GLC260动感+柏林，平时用车上下班居多，路况还行。纠结于凯迪的前悬麦弗逊，另外开车比较看中隔音和音响效果，凯迪试驾过，感觉还行，GLC试驾车没有装柏林，没有对比。个人感觉外形内饰偏向凯迪，但奔驰逼格高点。XT5全系优惠三万三，奔驰无活动，后期保养什么的两者对比会不会差很多？我的意思是奔驰的后期费用名声太大Ｖ__：生活在东北二线城市，媳妇想换车，目前开的是本田思域，主要上下班开，目前看中两款车，讴歌的CDX和宝马X1的1.5T，因媳妇为90后比较倾向于小众一些的CDX，但我认为讴歌毕竟比较小众，车的品质能够跟宝马相比么？抛开宝马X1最大的空间优势不谈请大咖帮忙给点意见！另，请大咖帮忙说说雅阁的混动怎么样？技术能够达到丰田的水平么？东北冬天的寒冷天气对混动车型会不会有什么影响？万分感谢！午夜巴黎：大众途观怎么样，发动机，行车隔音效果怎么样，需要注意什么？张猛：大师你好，想买一台百万SUV，全新XC90 T6、宝马X5、全新奥迪Q7，选哪一款？爱❤岩：大咖你们好，我是你们的忠实粉丝，通过你们的意见我买了新逍客，但是我去日产4S店保养的时候，为什么不同4S店的全合成机油不一样？都是5W-30，但是下面一个写的是SN/GF-5，一个写的是SM/GF-4，这到底是什么意思？它们之间有什么区别想请教您一下。我是在北方沈阳使用，用那个机油比较好？谢谢关注ams车评官方微信【微信号amscheping】参与「大咖说」栏目，向车圈大咖提问！
2016-10-2617 min
ams车评丨大咖说191期丨大咖说：凯迪拉克XT5对比奔驰GLC，应该怎么选？今日回答问题
撸迅：XT5，28t豪华四驱对比GLC260动感+柏林，平时用车上下班居多，路况还行。纠结于凯迪的前悬麦弗逊，另外开车比较看中隔音和音响效果，凯迪试驾过，感觉还行，GLC试驾车没有装柏林，没有对比。个人感觉外形内饰偏向凯迪，但奔驰逼格高点。XT5全系优惠三万三，奔驰无活动，后期保养什么的两者对比会不会差很多？我的意思是奔驰的后期费用名声太大
Ｖ__：生活在东北二线城市，媳妇想换车，目前开的是本田思域，主要上下班开，目前看中两款车，讴歌的CDX和宝马X1的1.5T，因媳妇为90后比较倾向于小众一些的CDX，但我认为讴歌毕竟比较小众，车的品质能够跟宝马相比么？抛开宝马X1最大的空间优势不谈请大咖帮忙给点意见！另，请大咖帮忙说说雅阁的混动怎么样？技术能够达到丰田的水平么？东北冬天的寒冷天气对混动车型会不会有什么影响？万分感谢！
午夜巴黎：大众途观怎么样，发动机，行车隔音效果怎么样，需要注意什么？
张猛：大师你好，想买一台百万SUV，全新XC90 T6、宝马X5、全新奥迪Q7，选哪一款？
爱❤岩：大咖你们好，我是你们的忠实粉丝，通过你们的意见我买了新逍客，但是我去日产4S店保养的时候，为什么不同4S店的全...
2016-10-2600 min
汽车玩家：说车 玩车 试车 购车 爱车必听车圈唠叨唠11：陈震撕X雷克萨斯/讴歌CDX上市1、售159.8万 奥迪RS 6 Avant正式上市
2、售22.98-30.98万 广汽讴歌CDX正式上市
3、售17.58-29.88万元 日产新款天籁上市
4、售17.98-26.98万 一汽丰田RAV4荣放上市
5、售18.99-31.69万 一汽-大众新迈腾上市
6、1300马力! 梅赛德斯-AMG将推超级跑车
7、换颗“德国心”捷豹路虎用宝马V8发动机
我们的微信公共平台“tangxiaoradio”或“Tom和他的小伙伴radio”，微博是“Tom和他的小伙伴电台”。Q群：435824530
2016-08-0140 min小编聊汽车车圈唠叨唠11：陈震撕X雷克萨斯/讴歌CDX上市1、售159.8万 奥迪RS 6 Avant正式上市
2、售22.98-30.98万 广汽讴歌CDX正式上市
3、售17.58-29.88万元 日产新款天籁上市
4、售17.98-26.98万 一汽丰田RAV4荣放上市
5、售18.99-31.69万 一汽-大众新迈腾上市
6、1300马力! 梅赛德斯-AMG将推超级跑车
7、换颗“德国心”捷豹路虎用宝马V8发动机
我们的微信公共平台“tangxiaoradio”或“Tom和他的小伙伴radio”，微博是“Tom和他的小伙伴电台”。Q群：435824530
2016-08-0140 min
汤小频道车圈唠叨唠11：陈震撕X雷克萨斯/讴歌CDX上市1、售159.8万 奥迪RS 6 Avant正式上市2、售22.98-30.98万 广汽讴歌CDX正式上市3、售17.58-29.88万元 日产新款天籁上市4、售17.98-26.98万 一汽丰田RAV4荣放上市5、售18.99-31.69万 一汽-大众新迈腾上市6、1300马力! 梅赛德斯-AMG将推超级跑车7、换颗“德国心”捷豹路虎用宝马V8发动机我们的微信公共平台“tangxiaoradio”或“Tom和他的小伙伴radio”，微博是“Tom和他的小伙伴电台”。Q群：435824530
2016-07-3140 min
Radio ilMonti.comLISTONE UNICO DI CDX SCELTA OBBLIGATA? I NUMERI DICONO DI NO.I numeri dicono che da soli, anche con l’italicum, prenderemmo più deputati di quelli che ci garantirebbe il listone unico di centrodestra
2016-03-0816 min
UNDER COUNTRY (podomatic rebroadcast)PM - Under Country 172http://www.undercountrymusic.com
THIS IS THE REBROADCAST OF UNDER COUNTRY MUSIC FOR THE LISTENERS OF PODOMATIC.
TO SUBSCRIBE TO THE PROPER FEED FOR THE SHOW, PLEASE CHOOSE ONE OF THE OPTIONS BELOW:
ITUNES LINK - https://itunes.apple.com/us/podcast/under-country-music/id870605900
RSS FEED - http://neil-smith.com/dandydjblog/undercountrymusic/feed/
UNDER COUNTRY MUSIC #172 - BUTT FOG AT THE OPRY
http://www.undercountrymusic.com
This week, Neil launches an intestinal gas attack on the Grand Ole Opry, encourages you to put Dierks in your mouth and curses the Huntsville Alabama PD... all while playing great music by...
courtesy...
2015-09-2043 minUNDER COUNTRY (podomatic rebroadcast)PM - Under Country 169http://www.undercountrymusic.com
THIS IS THE REBROADCAST OF UNDER COUNTRY MUSIC FOR THE LISTENERS OF PODOMATIC. TO SUBSCRIBE TO THE PROPER FEED FOR THE SHOW, PLEASE CHOOSE ONE OF THE OPTIONS BELOW:
ITUNES LINK - https://itunes.apple.com/us/podcast/under-country-music/id870605900
RSS FEED - http://neil-smith.com/dandydjblog/undercountrymusic/feed/
UNDER COUNTRY MUSIC #169 - REBEL FLAGS A-WAVIN’ !
http://www.undercountrymusic.com
This week, Neil puts up his Dukes of Hazzard, dishes on Maddie and Tae’s make-or-break and counts da money… all while playing great music by...
DSP Band - Give ‘Em A Hand - https://www.facebook...
2015-07-0937 minUNDER COUNTRY (podomatic rebroadcast)PM - Under Country 167http://www.undercountrymusic.com
THIS IS THE REBROADCAST OF UNDER COUNTRY MUSIC FOR THE LISTENERS OF PODOMATIC. TO SUBSCRIBE TO THE PROPER FEED FOR THE SHOW, PLEASE CHOOSE ONE OF THE OPTIONS BELOW:
ITUNES LINK - https://itunes.apple.com/us/podcast/under-country-music/id870605900
RSS FEED - http://neil-smith.com/dandydjblog/undercountrymusic/feed/
UNDER COUNTRY MUSIC #167 - COUNTRY HATH NO FURY!
http://www.undercountrymusic.com
CDX - Southern Halo - Little White Dress - http://southernhalo.squarespace.com/
CDX - Jerry Schmitt - With A Bottle And A Can - http://www.thejerryschmittband.com/
CDX - JB and the Moonshine...
2015-06-0546 min
Journal of Clinical Oncology (JCO) PodcastGlembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?A phase I/II study of the antibody-drug conjugate glembatumumab vedotin (CDX-011 or CR011-vcMMAE) in patients with locally advanced or metastatic breast cancer, reveals an acceptable safety profile and promising clinical activity in GPNMB expressing breast cancer.
2014-09-2911 min
Accidental Tech PodcastJourney Would Be Wasted On You
Follow-up on pCell and database scaling, including horizontal sharding schemes, tiered data layers, and taking a stand against the "premature optimization" tautology.
When and why do developers learn something new, and why does Marco keep using PHP for everything?
Second Crack
Fast Text
John's blog
OS X Beta Program for End Users
What's coming on June 2nd?
Casey and Marco make John proud (spoiler)
New third-generation Thunderbolt details
MagSafe vs. MagSafe 2
Overcast update
Are iPad sales leveling off? Why?
How we use our iPads today
Limitations in modern iOS
Are iPad apps stagnating?
Jean-Louis Gassée's take
Gruber's response
Casey o...
2014-04-252h 13